PTGS2 and prostate cancer: The use of aspirin (which inhibits cyclo-oxygenase 1 (COX-1) and 2 (COX-2) production) has been associated with a reduction in prostate cancer specific mortality in patients treated with radiotherapy or radical prostatectomy [38].